Several individual molecular biomarkers—such as circUGP2, lncRNA CASC15, and miR-338-3p—have demonstrated preliminary utility in reflecting tumor biology and predicting patient outcomes [39,47,48]. This evidence concerns the gene CASC15 and neoplasm.